Evaluation of U-AKIpredTM for Predicting AKI in Critically Ill Patients Within 12 Hours: a Multicenter Prospective Cohort Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of our study is to evaluate U-AKIpredTM for predicting AKI in critically ill patients within 12 h by the multicenter prospective cohorts. AKI was diagnosed by Kidney Disease Improving Global Outcomes (KDIGO) criteria. We designed five aspects including the overall fitting effecience evaluation, calibration curve, quantifying calibration performance, quantifying discrimination performance, quantifying clinical utility to evaluate the external validation model.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of AI Prediction Models in Prediction of Acute Kidney Injury in Critical Patients

NCT06857188

Acute Kidney Failure Artificial Intelligence (AI)

NOT_YET_RECRUITING

Parameters of the Recovery Time of Acute Kidney Injury in Critically Ill Patients

NCT06114693

AKI - Acute Kidney Injury

NOT_YET_RECRUITING

Preventing Acute Kidney Injury and Improving Outcome in Critically Ill Patients Utilising Risk Prediction Score

NCT03178435

Acute Kidney Injury Critical Illness

COMPLETED NA

Diagnostic Value of Urinary Indices in Differentiating Pre-renal and Renal Acute Kidney Injury

NCT02376712

Acute Kidney Injury

UNKNOWN

Acute Kidney Injury in Non-Critical Care Setting: Elaboration and Validation of an In-hospital Death Prognosis Score

NCT04242615

Intra-hospital Mortality Epidemiological Study

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

External Effectiveness Validation of Model

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* critically ill patients who stayed in ICU for over 24 h;
* patients older than 18 years of age.

Exclusion Criteria

* patients who admitted in ICU had been diagnosed acute kidney injury;
* patients who admitted in ICU had been diagnosed acute kidney disease;
* patients who admitted in ICU had been diagnosed chronic kidney disease;
* patients who admitted in ICU had performed kidney dialysis;
* patients who admitted in ICU had performed kidney transplantation;
* Pregnant women.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No